Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of estetrol + drospirenone vs Yasmin for contraception and liver function
2009-011858-17Phase 2Completed
- Sponsor
- Pantarhei Bioscience
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of estetrol + drospirenone (2 arms), sponsored by Pantarhei Bioscience. Primary endpoints: Ovulation inhibition and Hypothalamic-pituitary-ovarian function. Started Jun 2009; status: completed.
02
Drugs
estetrol + drospirenone
Beyond the preview
Go deeper on 2009-011858-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011858-17.